Microsomal triglyceride transfer protein inhibitor lomitapide-induced liver toxicity is ameliorated by Triiodothyronine treatment following improved bile homeostasis and β-oxidation-Reference-Cited by-同舟云学术

Microsomal triglyceride transfer protein inhibitor lomitapide-induced liver toxicity is ameliorated by Triiodothyronine treatment following improved bile homeostasis and β-oxidation

Published:2022-01 Issue: Volume:434 Page:115825
ISSN:0041-008X
Container-title:Toxicology and Applied Pharmacology
language:en
Short-container-title:Toxicology and Applied Pharmacology

Author:

Patel Vishal,Joharapurkar Amit,Kshirsagar Samadhan,Patel Maulik,Patel Hiren,Savsani Hardikkumar,Jain Mukul

Publisher

Elsevier BV

Subject

Pharmacology,Toxicology

Reference30 articles.

1. Defending plasma T3 is a biological priority;Abdalla;Clin. Endocrinol.,2014

2. The molecular actions of thyroid hormone in bone;Bassett;Trends Endocrinol. Metab.,2003

3. Stimulation of murine biliary cholesterol secretion by thyroid hormone is dependent on a functional ABCG5/G8 complex;Bonde;Hepatology (Baltimore, Md.),2012

4. Thyroid and cardiovascular disease research agenda for enhancing knowledge, prevention, and treatment;Cappola;Circulation,2019

5. Inhibition of microsomal triglyceride transfer protein improves insulin sensitivity and reduces atherogenic risk in Zucker fatty rats;Dhote;Clin. Exp. Pharmacol. Physiol.,2011

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inhibitory effect of trans-tiliroside on very low-density lipoprotein secretion in HepG2 cells and mouse liver;Journal of Natural Medicines;2023-11-16

2. The Beneficial Effect of Lomitapide on the Cardiovascular System in LDLr−/− Mice with Obesity;Antioxidants;2023-06-16

3. Efficacy of Long-Term Treatment of Autosomal Recessive Hypercholesterolemia With Lomitapide: A Subanalysis of the Pan-European Lomitapide Study;Frontiers in Genetics;2022-08-22

4. The microsomal triglyceride transfer protein inhibitor lomitapide improves vascular function in mice with obesity;Obesity;2022-03-06

5. Prolyl hydroxylase inhibitor desidustat improves anemia in erythropoietin hyporesponsive state;Current Research in Pharmacology and Drug Discovery;2022